Injectionby Paviour Pharmaceuticals Pvt Ltd
Curosurf 80mg Injection is used for respiratory distress syndrome (immature lungs in preterm baby). It is effective in babies who have difficulty breathing due to a lack of enough lubricants in their lungs. Curosurf 80mg Injection is given under the supervision of a healthcare professional in the hospital setting. Your doctor will decide how much you need to improve your symptoms Infants are continuously monitored to avoid any medical emergency. Pneumothorax (accumulation of air or gas in the chest or pleural space), brain hemorrhage, chronic lung disease, decreased oxygen level in the blood, and infection are some serious side effects of this medicine. Your doctor will be the best person to decide how to overcome the side effects.
Curosurf 80mg Injection is the surfactant given to premature babies to protect their lungs. The surfactant is a fatty substance that coats the inside or lining of the air sacs in the lungs. This coating prevents the air sacs from collapsing and sticking together when air leaves the lungs. The surfactant is produced by babies only after the 8th month of pregnancy.
Chemical Class :: Amino Acids, Peptides, and Analogues|Habit Forming :: No|Therapeutic Class :: RESPIRATORY|Action Class :: Pulmonary Surfactants
Consult a certified doctor for personalised medical advice.